1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Summary of the patient treatment and outcome data from the 12 included studies
Authors and Year Treatment Follow-Up (mo) Rerupture Occluded mRS Complications
PED Only PED + Coiling 0–2 3–5 Death All
Capocci et al,¹³ 2020 6/6 0/6 18.0 0/6 5/5 5/6 1/6 0/6 1/6
Lozupone et al,² 2018 12/14 2/14 NR 0/14 12/12 10/14 3/14 1/14 2/14
Cerejo et al,⁷ 2017 8/8 0/8 7.2 0/8 6/8 6/7 1/7 0/8 2/8
Linfante et al,³ 2017 10/10 0/10 15.2 0/10 9/9 8/10 1/10 1/10 1/10
Ryan et al,⁴ 2017 13/13 0/13 3.0 0/13 5/10 10/13 1/13 2/13 5/13
Chalouhi et al,¹¹ 2015 14/20 6/20 5.3 0/20 12/15 19/20 0/20 1/20 1/20
Lin et al,⁹ 2015 14/26 12/26 10.1 1/26 19/23 20/26 3/26 3/26 3/26
Chan et al,⁵ 2014 6/8 2/8 5.0 0/8 8/8 NR^{^a} NR^{^a} 0/8 1/8
Yoon et al,⁸ 2014 9/11 2/11 4.8 0/11 7/8 9/10 0/10 1/11 4/11
Cinar et al,⁶ 2013 6/6 0/6 7.0 0/6 6/6 4/6 2/6 0/6 0/6
McAuliffe et al,¹⁰ 2012 6/11 5/11 6.0 2/11 8/9 8/11 1/11 2/11 3/11
de Barrios Faria et al,¹² 2011 5/12 7/12 6.0 0/12 8/12 NR^{^a} NR^{^a} 0/12 0/12
Total 109/145 36/145 3/139 105/120 99/123 13/123 11/139 23/139
Range 3–18 
Note:—NR indicates not reported.
↵a Reported Glasgow Outcome Scale scores: grades 1–3: 3/8 (Chan et al), 6/12 (de Barrios Faria et al); grades 4–5: 5/8 (Chan et al), 6/12 (de Barrios Faria et al).